Showing 191-200 of 404 results for "".
- Cynosure's TempSure™ Envi Set to Debut at 2018 AAD Meetinghttps://modernaesthetics.com/news/cynosures-tempsure-envi-set-to-debut-at-2018-aad-meeting/2472144/Hologic's Cynosure division is launching TempSure™ Envi – an FDA-cleared advanced radiofrequency device. TempSure™ Envi heats the deep layers of skin to regenerate collagen and
- FDA OKs Describe Patch for Use with All Tattoo Removal Lasershttps://modernaesthetics.com/news/fda-oks-describe-patch-for-use-with-all-tattoo-removal-lasers/2472158/Merz North America’s DESCRIBE® PFD Patch is now cleared by the Food and Drug Administration (FDA) for all commonly used lasers for tattoo removal. The new FDA c
- Sculpture OK'd as Double Chin Treatmenthttps://modernaesthetics.com/news/sculpsure-oked-as-double-chin-treatment/2472190/Cynosure's SculpSure® is now cleared for submental fat reduction. The U.S. Food and Drug Administration (FDA) granted an expanded FDA 510(k) clearance for this area, Hologic, Inc. reports.
- Dr. Kelly Huang to Obalon; Alisa Lask to Oversee Galderma's Aesthetic & Corrective Business Unithttps://modernaesthetics.com/news/dr-kelly-huang-to-obalon-alisa-lask-to-oversee-galdermas-aesthetic-corrective-business-unit/2472202/Former Galderma general manager Kelly Huang, Ph.D. is now Obalon’s Chief Operating Officer. In this new role, Dr. Huang will be responsible for the key commercial functions of sales, marketing, operations, and quality assurance. In related
- Bonti's Gateway Neuromodulator Performs Well in Phase 2A Studyhttps://modernaesthetics.com/news/bontis-gateway-neuromodulator-performs-well-in-pase-2a-for-glabellar-lines/2472208/Bonti’s lead product candidate, EB- 001, passed muster in a Phase 2A study for the treatment of glabellar lines. EB-001 is a novel serot
- Sculpture OK'd for Back, Inner and Outer Thighshttps://modernaesthetics.com/news/sculpsure-oked-for-back-inner-and-outer-thighs/2472220/The U.S. Food and Drug Administration (FDA) granted an expanded clearance for Cynosure's SculpSure to treat the back and inner and outer thighs. The SculpSure treatment is already FDA-cleared for treatment of the abdom
- Read Their Lips: Avoid Unnatural Lip Enhancement Results With This Datahttps://modernaesthetics.com/news/read-their-lips-avoid-unnatural-lip-enhancement-results-with-this-data/2472247/Many a Real Housewife from Bravo’s hit reality TV franchise have been chastised for trout pout – or an overfilled, unnatural looking pucker. And now a new study, published by JAMA Facial
- Hugel Marks 15 Years of Letybo with 2025 H.E.L.F Symposium in Seoulhttps://modernaesthetics.com/news/hugel-marks-15-years-of-letybo-with-2025-helf-symposium-in-seoul/2483385/More than 220 medical professionals from across the globe gathered in Seoul on September 14 for Hugel Inc.’s 2025 H.E.L.F. symposium, marking 15 years since the launch of its botulinum toxin, Letybo. The Hugel Expert Leader’s Forum was held at Seoul Dragon City under the theme, “K-Beau
- 2025 AAD: What’s New and True for Energy-Based Deviceshttps://modernaesthetics.com/news/2025-aad-whats-new-and-true-for-energy-based-devices/2473763/At the 2025 American Academy of Dermatology (AAD) Annual Meeting, Modern Aesthetics sat in on “What’s New and What’s True for Energy-Based Devices (EBDs).” The speakers of this lecture included Suzanne L Kilmer, MD, FAAD; Arielle N.B. Kauvar, MD, FAAD; Merete Haedersdal, MD, PhD, FAAD; Jill S. Wa
- 2025 AAD Meeting: Innovations for Treatment of Burn and Trauma Scarshttps://modernaesthetics.com/news/2025-aad-meeting-innovations-for-treatment-of-burn-and-trauma-scars/2473755/The use of lasers and energy-based device technology to treat different types of scars continues to evolve. Arielle N.B. Kauvar, MD, FAAD; Kristen Marie Kelly, MD, FAAD; Girish S. Munavalli, MD, MHS, FAAD; and Jill Waibel, MD, FAAD, explored the traditional and cutting-edge techniques for correct